Experiment Eleven: Dark Secrets Behind the Discovery of a Wonder Drug

Experiment Eleven: Dark Secrets Behind the Discovery of a Wonder Drug


In 1943, Albert Schatz, a tender Rutgers collage Ph.D. pupil, labored on a wartime venture in microbiology professor Selman Waksman's lab, looking for an antibiotic to struggle infections at the entrance traces and at domestic. In his 11th test on a standard bacterium present in farmyard soil, Schatz came across streptomycin, the 1st potent healing for tuberculosis, one of many world's deadliest ailments.

As director of Schatz's learn, Waksman took credits for the invention, belittled Schatz's paintings, and secretly enriched himself with royalties from the streptomycin patent filed by way of the pharmaceutical corporation Merck. In an exceptional lawsuit, younger Schatz sued Waksman, and was once provided the identify of "co-discoverer" and a percentage of the royalties. yet years later, Professor Waksman on my own used to be provided the Nobel Prize. Schatz disappeared into educational obscurity.

For the 1st time, acclaimed writer and journalist Peter Pringle unravels the intrigues at the back of probably the most vital discoveries within the background of medication. the tale unfolds on a tiny university campus in New Jersey, yet its repercussions unfold world wide. The streptomycin patent was once a leap forward for the drug businesses, overturning patent limits on items of nature and paving the way in which for state-of-the-art biotech international. As dozens extra antibiotics have been chanced on, many from an identical family members as streptomycin, the drug businesses created oligopolies and reaped substantial earnings. Pringle makes use of firsthand money owed and information within the usa and Europe to bare the intensely human tale in the back of the invention that began a revolution within the therapy of infectious illnesses and formed the way forward for vast Pharma.

Show sample text content

Download sample